Anixa Biosciences Inc (ANIX)

$3.15 -0.11 (-3.37%)
Market Cap 105.01M
Revenue (ttm) 0.00
Net Income (ttm) -12.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 50,500
Avg Vol 160,166
Day's Range N/A - N/A
Shares Out 32.21M
Stochastic %K 37%
Beta 0.43
Analysts Strong Sell
Price Target $9.00

Company Profile

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 708 9808
Address:
3150 Almaden Expressway, Suite 250, San Jose, United States
JarvisFlow
JarvisFlow Aug. 5 at 12:00 PM
D. Boral Capital has adjusted their stance on Anixa Biosciences ( $ANIX ), setting the rating to Buy with a target price of 10.
0 · Reply
XkaliburTrading
XkaliburTrading Aug. 5 at 11:49 AM
$ANIX https://newsfilter.io/articles/d-boral-capital-maintains-buy-on-anixa-biosciences-maintains-10-price-target-c188d0b0cef7c98f2640aeb64d1c6471
0 · Reply
bioinvestorrr
bioinvestorrr Aug. 4 at 7:07 PM
$ANIX should be much higher imo
0 · Reply
stockobserver51
stockobserver51 Aug. 4 at 6:57 PM
$ANIX That's great news after a long time.
0 · Reply
prismmarketview
prismmarketview Aug. 4 at 2:15 PM
$ANIX @AnixaBio moves closer to a Phase 2 trial for its breast cancer vaccine after positive Phase 1 results, taking over the IND from Cleveland Clinic. https://prismmarketview.com/anixa-biosciences-advances-breast-cancer-vaccine-toward-phase-2-clinical-trial-with-ind-transfer/
0 · Reply
StockRedBaron
StockRedBaron Aug. 4 at 1:18 PM
$ANIX Hey Guys, I'm new to this ticker, it sounds like great news---Any thoughts why it's not running??...Wait til Open?
0 · Reply
Kher33
Kher33 Aug. 4 at 1:09 PM
$ANIX https://ir.anixa.com/press-releases/detail/1090
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 31 at 3:05 PM
$ANIX CEO purchased 5,000 shares at $3.16 for a total of $15,800. KUMAR AMIT now owns 579,925 shares. https://ceo-buys.com
0 · Reply
SocioCobb
SocioCobb Jul. 31 at 2:09 PM
$ANIX CEO just made a small purchase ($15K). Nothing to see. Whats the deal here?
3 · Reply
stockobserver51
stockobserver51 Jul. 30 at 2:14 PM
$ANIX Today, $2.90. No income, but many expenses for patent approvals cost a lot of money.
0 · Reply
Latest News on ANIX
Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial

Aug 4, 2025, 8:45 AM EDT - 1 day ago

Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial

Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology

Jul 30, 2025, 8:15 AM EDT - 6 days ago

Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology

Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s

Jul 24, 2025, 8:00 AM EDT - 12 days ago

Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s

Anixa Biosciences: Oncology Platform With Asymmetric Upside

Jul 15, 2025, 3:49 PM EDT - 21 days ago

Anixa Biosciences: Oncology Platform With Asymmetric Upside

Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology

Jul 9, 2025, 8:00 AM EDT - 27 days ago

Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Jun 23, 2025, 8:00 AM EDT - 6 weeks ago

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Jun 20, 2025, 7:30 AM EDT - 6 weeks ago

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Jun 10, 2025, 7:00 AM EDT - 2 months ago

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025

Jun 9, 2025, 8:00 AM EDT - 2 months ago

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview

Jun 3, 2025, 7:25 AM EDT - 2 months ago

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

Jun 2, 2025, 7:00 AM EDT - 2 months ago

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

May 19, 2025, 8:00 AM EDT - 2 months ago

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

May 12, 2025, 8:00 AM EDT - 3 months ago

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

Apr 30, 2025, 8:00 AM EDT - 3 months ago

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio

Apr 14, 2025, 8:00 AM EDT - 4 months ago

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

Apr 9, 2025, 8:00 AM EDT - 4 months ago

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

Apr 1, 2025, 8:00 AM EDT - 4 months ago

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Mar 25, 2025, 8:00 AM EDT - 4 months ago

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Mar 24, 2025, 8:00 AM EDT - 4 months ago

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

Mar 17, 2025, 8:00 AM EDT - 5 months ago

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Mar 10, 2025, 8:30 AM EDT - 5 months ago

Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

Mar 3, 2025, 8:00 AM EST - 5 months ago

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

Feb 26, 2025, 8:00 AM EST - 5 months ago

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

Feb 25, 2025, 7:30 AM EST - 5 months ago

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

Feb 24, 2025, 8:00 AM EST - 5 months ago

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

Feb 18, 2025, 8:00 AM EST - 6 months ago

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

Feb 14, 2025, 7:00 AM EST - 6 months ago

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

Feb 11, 2025, 8:30 AM EST - 6 months ago

Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention

Feb 4, 2025, 8:30 AM EST - 6 months ago

Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention

Anixa Biosciences CEO Provides Letter to Shareholders

Jan 21, 2025, 8:30 AM EST - 7 months ago

Anixa Biosciences CEO Provides Letter to Shareholders

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Dec 4, 2024, 8:30 AM EST - 8 months ago

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Nov 22, 2024, 8:15 AM EST - 9 months ago

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

Nov 18, 2024, 8:20 AM EST - 9 months ago

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 8, 2024, 1:17 PM EST - 9 months ago

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 6, 2024, 8:30 AM EST - 9 months ago

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Oct 31, 2024, 8:15 AM EDT - 9 months ago

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 28, 2024, 8:30 AM EDT - 10 months ago

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

Oct 15, 2024, 9:00 AM EDT - 10 months ago

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

Oct 7, 2024, 8:30 AM EDT - 10 months ago

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

Sep 30, 2024, 8:30 AM EDT - 11 months ago

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Sep 24, 2024, 8:30 AM EDT - 11 months ago

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

Sep 18, 2024, 8:30 AM EDT - 11 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

Sep 3, 2024, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 26, 2024, 8:30 AM EDT - 1 year ago

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

Jul 29, 2024, 8:45 AM EDT - 1 year ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

Jul 23, 2024, 8:15 AM EDT - 1 year ago

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

Jul 17, 2024, 8:00 AM EDT - 1 year ago

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

Anixa Biosciences Announces $5 Million Share Repurchase Program

Jul 15, 2024, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces $5 Million Share Repurchase Program

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

Jun 24, 2024, 8:45 AM EDT - 1 year ago

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

May 21, 2024, 7:30 AM EDT - 1 year ago

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

JarvisFlow
JarvisFlow Aug. 5 at 12:00 PM
D. Boral Capital has adjusted their stance on Anixa Biosciences ( $ANIX ), setting the rating to Buy with a target price of 10.
0 · Reply
XkaliburTrading
XkaliburTrading Aug. 5 at 11:49 AM
$ANIX https://newsfilter.io/articles/d-boral-capital-maintains-buy-on-anixa-biosciences-maintains-10-price-target-c188d0b0cef7c98f2640aeb64d1c6471
0 · Reply
bioinvestorrr
bioinvestorrr Aug. 4 at 7:07 PM
$ANIX should be much higher imo
0 · Reply
stockobserver51
stockobserver51 Aug. 4 at 6:57 PM
$ANIX That's great news after a long time.
0 · Reply
prismmarketview
prismmarketview Aug. 4 at 2:15 PM
$ANIX @AnixaBio moves closer to a Phase 2 trial for its breast cancer vaccine after positive Phase 1 results, taking over the IND from Cleveland Clinic. https://prismmarketview.com/anixa-biosciences-advances-breast-cancer-vaccine-toward-phase-2-clinical-trial-with-ind-transfer/
0 · Reply
StockRedBaron
StockRedBaron Aug. 4 at 1:18 PM
$ANIX Hey Guys, I'm new to this ticker, it sounds like great news---Any thoughts why it's not running??...Wait til Open?
0 · Reply
Kher33
Kher33 Aug. 4 at 1:09 PM
$ANIX https://ir.anixa.com/press-releases/detail/1090
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 31 at 3:05 PM
$ANIX CEO purchased 5,000 shares at $3.16 for a total of $15,800. KUMAR AMIT now owns 579,925 shares. https://ceo-buys.com
0 · Reply
SocioCobb
SocioCobb Jul. 31 at 2:09 PM
$ANIX CEO just made a small purchase ($15K). Nothing to see. Whats the deal here?
3 · Reply
stockobserver51
stockobserver51 Jul. 30 at 2:14 PM
$ANIX Today, $2.90. No income, but many expenses for patent approvals cost a lot of money.
0 · Reply
rickycv
rickycv Jul. 30 at 1:31 PM
$ANIX $3.50 today!?
0 · Reply
Goldenjon55
Goldenjon55 Jul. 30 at 12:46 PM
$ANIX https://ir.anixa.com/press-releases/detail/1089/anixa-biosciences-receives-notice-of-allowance-from
0 · Reply
justiceforb_85
justiceforb_85 Jul. 30 at 12:48 AM
$ANIX when do we receive an update on CAR-T for ovarian cancer?
0 · Reply
Rick87
Rick87 Jul. 29 at 5:50 PM
$ANIX Started small position , will buy if it descends in 5-11 % intervals. Feel ok at this start 3.13
0 · Reply
jeojackson
jeojackson Jul. 27 at 1:43 PM
$ANIX Not enough volume.
0 · Reply
SCUBus
SCUBus Jul. 24 at 12:26 PM
$ANIX Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s https://ir.anixa.com/press-releases/detail/1088
0 · Reply
stockobserver51
stockobserver51 Jul. 22 at 6:43 PM
$ANIX If it doesn't go toward $7, applause! Gamblers and short sellers are celebrating again. Off to the basement.
0 · Reply
stockobserver51
stockobserver51 Jul. 22 at 6:15 PM
$ANIX If it doesn't go toward $7, applause! Gamblers and short sellers are celebrating again. Off to the basement.
0 · Reply
Poppy999
Poppy999 Jul. 21 at 10:22 PM
$BRCC $PETS $ANIX
0 · Reply
rickycv
rickycv Jul. 21 at 2:53 PM
$ANIX Another insider just bought 5k shares.
0 · Reply
AZOZ
AZOZ Jul. 21 at 1:58 PM
$BRCC $PETS $ANIX Insider's love it right now!
0 · Reply
Chartist0_0
Chartist0_0 Jul. 17 at 12:52 PM
$ANIX Insiders have been stampeding into this stock in the low 3s.
0 · Reply